Abiopharma

Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.

Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.

Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA

Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies

Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum

Tonix Pharmaceuticals Announces Pricing of $20.0 Million Registered Direct Offering

Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800)

Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)

Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)